In vitro and in vivo responses of a panel of murine colon tumours to TCNU: a positive correlation
- PMID: 3181258
- DOI: 10.1016/0277-5379(88)90230-1
In vitro and in vivo responses of a panel of murine colon tumours to TCNU: a positive correlation
Abstract
TCNU is highly active against a panel of three histologically distinct transplantable murine adenocarcinomas of the colon (MAC tumours). Significant reductions in colony formation (greater than 70%) were observed in vitro in all three cell lines following a 1 h exposure to TCNU at experimentally achievable drug C X t values. A good correlation exists between in vivo tumour responses and in vitro cell responses in all cases. Dose-response curves generated at increasing exposure times suggest that no active or long lived products of TCNU are formed as a result of the drug's spontaneous breakdown in vitro (rate of breakdown was 0.078 micrograms min-1 at 37 degrees C). Preliminary studies with the HT-29 human colon cell line have demonstrated that multi-cellular spheroids are more responsive to TCNU (2 X) than the same cells cultured as monolayers.
Similar articles
-
The influence of hydralazine on the vasculature, blood perfusion and chemosensitivity of MAC tumours.Br J Cancer. 1992 Aug;66(2):323-30. doi: 10.1038/bjc.1992.264. Br J Cancer. 1992. PMID: 1503906 Free PMC article.
-
Anti-tumour activity of TCNU in a panel of transplantable murine colon tumours.Eur J Cancer Clin Oncol. 1988 Aug;24(8):1361-4. doi: 10.1016/0277-5379(88)90229-5. Eur J Cancer Clin Oncol. 1988. PMID: 3181257
-
Anti-tumour, toxicological and pharmacokinetic properties of a novel taurine-based nitrosourea (TCNU).Invest New Drugs. 1988 Apr;6(1):19-30. doi: 10.1007/BF00170775. Invest New Drugs. 1988. PMID: 3410663
-
Genotoxicity of tauromustine, a new water soluble taurine-based nitrosourea. I. Mutagenic and clastogenic activity of tauromustine in vitro.Mutagenesis. 1992 Nov;7(6):427-31. doi: 10.1093/mutage/7.6.427. Mutagenesis. 1992. PMID: 1474918
-
TCNU: a ray of hope for designer nitrosoureas?Eur J Cancer Clin Oncol. 1987 Dec;23(12):1823-8. doi: 10.1016/0277-5379(87)90046-0. Eur J Cancer Clin Oncol. 1987. PMID: 3325292 Review. No abstract available.
Cited by
-
The influence of hydralazine on the vasculature, blood perfusion and chemosensitivity of MAC tumours.Br J Cancer. 1992 Aug;66(2):323-30. doi: 10.1038/bjc.1992.264. Br J Cancer. 1992. PMID: 1503906 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Miscellaneous